Advertisement
Logo
Search for

Articles in Press

Return to articles in press list

Value of 3.0T MR imaging in refractory partial epilepsy and negative 1.5T MRI

Dang Khoa NguyenaCorresponding Author Informationemail address, Émilie Rochettea, Jean-Maxime Lerouxb, Gilles Beaudoinb, Patrick Cossettea, Maryse Lassondecd, François Guilbertb

Received 1 February 2010; accepted 1 July 2010. published online 30 July 2010.
Corrected Proof

Abstract 

Background

High-field 3.0T MR scanners provide an improved signal-to-noise ratio which can be translated in higher image resolution, possibly allowing critical detection of subtle epileptogenic lesions missed on standard-field 1.0–1.5T MRIs. In this study, the authors explore the potential value of re-imaging at 3.0T patients with refractory partial epilepsy and negative 1.5T MRI.

Methods

We retrospectively identified all patients with refractory partial epilepsy candidate for surgery who had undergone a 3.0T MR study after a negative 1.5T MR study. High-field 3.0T MRIs were reviewed qualitatively by neuroradiologists experienced in interpreting epilepsy studies with access to clinical information. Relevance and impact on clinical management were assessed by an epileptologist.

Results

Between November 2006 and August 2009, 36 patients with refractory partial epilepsy candidate for surgery underwent 3.0T MR study after a 1.5T MR study failed to disclose a relevant epileptogenic lesion. A potential lesion was found only in two patients (5.6%, 95% CI: 1.5–18.1%). Both were found to have hippocampal atrophy congruent with other presurgical localization techniques which resulted in omission of an invasive EEG study and direct passage to surgery.

Conclusions

The frequency of detection of a new lesion by re-imaging at 3.0T patients with refractory partial epilepsy candidate for surgery was found to be low, but seems to offer the potential of a significant clinical impact for selected patients. This finding needs to be validated in a prospective controlled study.

a Service de Neurologie, Hôpital Notre-Dame du CHUM, Université de Montréal, Canada

b Département de Radiologie, Hôpital Notre-Dame du CHUM, Université de Montréal, Canada

c Centre de Recherche en Neuropsychologie et Cognition, Université de Montréal, Canada

d Centre de Recherche, Centre Hospitalier Universitaire Ste-Justine Université de Montréal, Montréal, QC, Canada

Corresponding Author InformationCorresponding author at: Service de Neurologie, Hôpital Notre-Dame du CHUM, 1560 rue Sherbrooke Est, Montréal, Québec, H2L 4M1, Canada. Tel.: +1 514 890 8237; fax: +1 514 412 7554.

PII: S1059-1311(10)00147-0

doi:10.1016/j.seizure.2010.07.002